Last reviewed · How we verify
If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Pf-07941944 | pf-07941944 | Pfizer | Small molecule | Not specified |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources:
- If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources treatment updates — RSS
- If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources treatment updates — Atom
- If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources treatment updates — JSON
Cite this brief
Drug Landscape (2026). If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/if-you-need-to-know-the-indications-for-this-drug-i-recommend-checking-the-fda-website-or-other-reliable-sources. Accessed 2026-06-10.
Related
- If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing